Iapyx Medical(TM), a developer of innovative medical devices, today announced a $9 million investment by Tavistock Life Sciences, bringing the Company's total funding to more than $12 million.
Hospital-acquired infections add an enormous financial strain of over $5 billion annually on the healthcare system and are associated with the fourth leading cause of death in the U.S. "Hospital-acquired infections impact one in every 10 patients in the U.S. with approximately 90,000 patients dying annually," said Shehan Dissanayake, CEO of Tavistock Life Sciences.
The company has re-named itself after Iapyx, a wound healer and battlefield surgeon in Greek mythology who is one of the first people credited with identifying and treating the problem of surgical site infections.
Iapyx or Lycaon, removing an arrowhead from Aeneas thigh using a forceps.
Aenas is shown with his young crying son Iulus Ascanius.
Even of divine origin Iapyx is not successful and Aphrodite his mother intervenes (the woman behind Iapyx) by giving her son a herb from the island of Crete (or Asia?), dittany, to be used to heal the wound.
Feeds |
Contact